Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection

Latent Tuberculosis Infection in Korean Health Care Workers

NCT03010111 ·Status: UNKNOWN ·Phase: NA

Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts

NCT02454738 ·Status: COMPLETED ·Phase: NA

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

NCT02288481 ·Status: COMPLETED ·Phase: PHASE1

Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis

NCT06054334 ·Status: UNKNOWN

Multi-Drug Resistant Tuberculosis in Korea

NCT00341601 ·Status: COMPLETED

The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study

NCT01182259 ·Status: UNKNOWN

Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)

NCT05280886 ·Status: UNKNOWN

Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

NCT00341328 ·Status: COMPLETED ·Phase: PHASE3

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

NCT03470233 ·Status: COMPLETED

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

NCT03822156 ·Status: COMPLETED

Potential Role of Microbiome in Tuberculosis

NCT04985994 ·Status: COMPLETED

Determining Risk in Latent Tuberculosis

NCT01571739 ·Status: TERMINATED

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

NCT03830671 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Intravenous Treatment of Tuberculosis

NCT04150367 ·Status: TERMINATED

Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial

NCT05738681 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs

NCT00979290 ·Status: COMPLETED

Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB

NCT01392911 ·Status: COMPLETED ·Phase: PHASE2

Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

NCT07003581 ·Status: COMPLETED

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers

NCT02387242 ·Status: SUSPENDED ·Phase: PHASE1

Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients

NCT03211208 ·Status: COMPLETED

A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK

NCT02836483 ·Status: COMPLETED ·Phase: PHASE2

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

NCT07126639 ·Status: NOT_YET_RECRUITING ·Phase: NA

Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis

NCT03160638 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

NCT02349841 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

NCT04493671 ·Status: COMPLETED ·Phase: PHASE1